KJCKorea
Journal Central

@article{ART002559222},
author={Sazid Alam and MD Anzar Alam and Ghulamuddin Sofi and Mohd. Qudratullah Khan and Shabnam Ansari},
title={A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia},
journal={CELLMED},
issn={3022-6805},
year={2020},
volume={10},
number={1},
pages={8-8},
doi={10.5667/tang.2020.0008}

TY - JOUR
AU - Sazid Alam
AU - MD Anzar Alam
AU - Ghulamuddin Sofi
AU - Mohd. Qudratullah Khan
AU - Shabnam Ansari
TI - A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia
JO - CELLMED
PY - 2020
VL - 10
IS - 1
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 8
EP - 8
SN - 3022-6805
AB - Aim:‘Itrifal-e-Sagheer’, a compound Unani formulation has been indicated in disease conditions simulating dyslipidemia. The present study was done to substantiate the efficacy of ‘Itrifal-e-Sagheer’ in dyslipidemia on scientific parameters. Materials and methods: A randomized, single blind, controlled, clinical trial was carried out on 30 patients of dyslipidemia who were randomly allocated into test (n = 15) or control (n = 15) groups. The test drug, Itrifal-e-Sagheer and control drug, Abana® were given to respective group for 45 days along with lifestyle modification. Results: The test drug significantly alleviated the symptoms of subjective parameters (palpitation, breathlessness and weight gain) (p<0.05). There was statistically significant reduction in lipid profile of the patients in test group (p<0.05) than control drug treatment. Conclusion: The study evidenced that Itrifal-e-Sagheer is potentially effective and safe in the treatment of dyslipidemia. However, a multicentric study with robust study design is required to generalize the results.
KW - Dyslipidemia. Itrifale sagheer. Unani medicine. Clinical trial. Obesity. Abana
DO - 10.5667/tang.2020.0008
ER -

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan and Shabnam Ansari. (2020). A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. CELLMED, 10(1), 8-8.

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan and Shabnam Ansari. 2020, "A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia", CELLMED, vol.10, no.1 pp.8-8. Available from: doi:10.5667/tang.2020.0008

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan, Shabnam Ansari "A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia" CELLMED 10.1 pp.8-8 (2020) : 8.

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan, Shabnam Ansari. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. 2020; 10(1), 8-8. Available from: doi:10.5667/tang.2020.0008

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan and Shabnam Ansari. "A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia" CELLMED 10, no.1 (2020) : 8-8.doi: 10.5667/tang.2020.0008

Sazid Alam; MD Anzar Alam; Ghulamuddin Sofi; Mohd. Qudratullah Khan; Shabnam Ansari. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. CELLMED, 10(1), 8-8. doi: 10.5667/tang.2020.0008

Sazid Alam; MD Anzar Alam; Ghulamuddin Sofi; Mohd. Qudratullah Khan; Shabnam Ansari. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. CELLMED. 2020; 10(1) 8-8. doi: 10.5667/tang.2020.0008

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan, Shabnam Ansari. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. 2020; 10(1), 8-8. Available from: doi:10.5667/tang.2020.0008

Sazid Alam, MD Anzar Alam, Ghulamuddin Sofi, Mohd. Qudratullah Khan and Shabnam Ansari. "A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia" CELLMED 10, no.1 (2020) : 8-8.doi: 10.5667/tang.2020.0008